The DOI matches its Crossref record; 98 of the 101 references it cites were found in a registry or an index; 29 of the 47 sources its claims cite were checked for support.
Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain
Open accessAbstract
Microglia become progressively activated and seemingly dysfunctional with age, and genetic studies have linked these cells to the pathogenesis of a growing number of neurodegenerative diseases. Here we report a striking buildup of lipid droplets in microglia with aging in mouse and human brains. These cells, which we call 'lipid-droplet-accumulating microglia' (LDAM), are defective in phagocytosis, produce high levels of reactive oxygen species and secrete proinflammatory cytokines. RNA-sequencing analysis of LDAM revealed a transcriptional profile driven by innate inflammation that is distinct from previously reported microglial states. An unbiased CRISPR-Cas9 screen identified genetic modifiers of lipid droplet formation; surprisingly, variants of several of these genes, including progranulin (GRN), are causes of autosomal-dominant forms of human neurodegenerative diseases. We therefore propose that LDAM contribute to age-related and genetic forms of neurodegeneration.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Aging microglia in mouse and human hippocampus accumulate lipid droplets, defining a lipid droplet-accumulating microglia (LDAM) state with impaired phagocytosis, high ROS, and pro-inflammatory cytokine release. CRISPR-Cas9 screening links lipid droplet formation to neurodegeneration-associated genes, and GRN−/− mice show a similar LDAM-like phenotype.
Key findings
- Lipid droplets were more abundant in aged mouse hippocampal microglia: BODIPY+ TMEM119+ microglia were 51.95% in aged versus 12.08% in young mice, and CARS+ lipid-storing microglia were 50.76% versus 18.93%; aged human hippocampus also had more Plin2+ Iba1+ microglia.
- LDAM had a distinct transcriptome with 692 differentially expressed genes between BODIPYlo and BODIPYhi aged microglia; top pathways included phagosome maturation and NO/ROS production, with LPS predicted as the most significant upstream regulator.
- LDAM showed functional defects: in acute slices, Zymosan+ BODIPY+ microglia were 2.1% versus 24.3% for BODIPY− microglia; LD-hi aged microglia had twofold higher CellROX signal than LD-lo microglia and released more CCL3, CXCL10, IL-6 at baseline plus exaggerated cytokines after LPS.
- A CRISPR-Cas9 screen identified 112 significant regulators of lipid droplet formation (P<0.05; FDR<50%), including SLC33A1, SNX17, GRN, VPS35, CLN3, and NPC2; GRN−/− mice had twofold more BODIPY+ microglia and twice as many lipid droplets per cell, with LD-hi GRN−/− microglia transcriptionally and functionally similar to LDAM.
Methods
- Aging mouse microglia were studied by TEM, BODIPY/immunohistochemistry, CARS microscopy, lipidomics, and RNA-seq of FACS-sorted CD11b+CD45lo BODIPYlo versus BODIPYhi hippocampal microglia; human postmortem hippocampus included young adult (<35 years, n=3) and elderly (>60 years, n=5) samples.
- In vitro and in vivo models included BV2 microglia treated with LPS, Triacsin C, or aged plasma; LPS-treated young mice; organotypic brain slices and hippocampal myelin-debris injection for phagocytosis; CellROX for ROS; multiplex cytokine assays; and a pooled CRISPR-Cas9 screen using iodo-BODIPY photoablation.
- Analyses used DESeq2 for RNA-seq, IPA/Enrichr for pathways, and GraphPad Prism with t-tests, Mann–Whitney U-tests, or ANOVA followed by Tukey’s post hoc tests.
Limitations
- The paper states that the role of LDAM in brain aging and disease remains to be defined, that pharmacological and genetic ablation experiments are required, and that mechanisms linking lipid droplets to phagocytosis, ROS, and state conversion remain unresolved.
- Evident from the text: all animal experiments used male mice only, human tissue was limited to small postmortem samples without neurological or psychiatric diagnoses, and human lipid droplets were detected by Plin2 rather than BODIPY because antigen retrieval removes lipids.
- Evident from the text: much mechanistic work relies on the BV2 microglial cell line, and the CRISPR screen used an FDR<50% significance threshold; some single-knockout BV2 lines were polyclonal, except GRN knockout cells, which were sub-cloned.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
93 Own result · 24 Own interpretation · 14 Own method · 13 No full text of the sources · 10 Couldn’t confirm · 9 Partly supported · 3 Supported · 3 No basis given · 1 Supported so far · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Aged microglia are one of the main sources of increased ROS levels in the aging brain2, and excessive microglial ROS production might contribute to age-related CNS dysfunctions.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM produce high levels of ROS and show excessive release of pro-inflammatory cytokines
What the sources say
- Partly supportedcites [2] Mosher, K. I. & Wyss-Coray, T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem. Pharmacol. 88, 594–604 (2014). sourceExperimental — accuracy not yet measured
Section 4.4 says oxidative stress increases with aging and that NOX2 contributes to microglial ROS production in an LPS-induced inflammation model. It calls microglial NADPH oxidase a believed primary ROS source in the context of Alzheimer’s disease, but does not establish aged microglia as a main source of increased ROS in the aging brain generally. No page number was provided in our copy. (LLM, conf=0.85)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“By using pooled CRISPR-Cas9 targeted screening, we discovered genes for which variants cause autosomal dominant forms of neurodegeneration (SLC33A1, SNX17, GRN, VPS35, CLN3, NPC2) as genetic modulators of lipid droplet formation in microglia32–35.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
What the sources say
- Could not verifycites [32] Kamkaew, A. et al. BODIPY dyes in photodynamic therapy. Chem. Soc. Rev. 42, 77–88 (2013). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [33] Lee, J. et al. Adaptor protein sorting nexin 17 regulates amyloid precursor protein trafficking and processing in the early endosomes. J. Biol. Chem. 283, 11501–11508 (2008). source
- Supportedcites [34] Liu, P. et al. S113R mutation in SLC33A1 leads to neurodegeneration and augmented BMP signaling in a mouse model. Dis. Model. Mech. 10, 53–62 (2017). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Supportedcites [35] Huey, E. D. et al. Characteristics of frontotemporal dementia patients with a progranulin mutation. Ann. Neurol. 60, 374–380 (2006). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“For example, lipid droplets in microglia have been detected in adult mice after induction of ROS by rotenone13, in hippocampal slice culture from P6–8 mice upon treatment with LPS, and in LPS-treated cells of the microglia-like cell line N916.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Supportedcites [16] Chang, P. K., Khatchadourian, A., McKinney, R. A. & Maysinger, D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J. Neuroinflammation 12, 34 (2015). source
The Methods section says the organotypic hippocampal slice cultures were prepared from P6–8 mice and subsequently treated with LPS. The Results section reports lipid bodies in microglia in those LPS-treated cultures, including an increase in large lipid bodies. The slices were cultured for three weeks before treatment, which does not change the claim about the mice's age when the slices were prepared. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The finding of lipid droplet containing microglia in GRN−/− mice is corroborated by a recent study which showed that cultured progranulin-deficient macrophages exhibited increased foam cell formation, i.e. lipid droplet accumulation, compared to wild type macrophages49.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
What the sources say
- Could not verifycites [49] Jaitin, D. A. et al. Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell 178, 686–698.e14 (2019). sourceExperimental — accuracy not yet measured
The Results section on Trem2-dependent macrophage remodeling reports reduced lipid uptake and storage in Trem2-deficient macrophages, not increased foam-cell formation in progranulin-deficient cultures. Searches for progranulin, GRN, and foam cells found no passage in our copy comparing cultured progranulin-deficient macrophages with wild-type macrophages; page numbers were not available. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“In addition, a recent study reported that loss of GRN leads to intracellular and intra-lysosomal accumulation of long polyunsaturated triacylglyerides50 in the brains of humans and mice.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
What the sources say
- Could not verifycites [50] Nguyen, A. D et al. Progranulin in the hematopoietic compartment protects mice from atherosclerosis. Atherosclerosis 277, 145–154 (2018). sourceExperimental — accuracy not yet measured
The Introduction and the Results section on lysosomal abnormalities describe increased lysosomal markers in Grn-deficient mouse brains and macrophages. Neither those passages nor searches for polyunsaturated triacylglycerides and triglycerides report accumulation of those lipids in human or mouse brains. The finding that neutral lipids did not accumulate in lysosomes concerns cultured macrophages under a specific treatment, not brains. (LLM, conf=0.72)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lastly, we detected Perilipin 2, a close paralog of Perilipin 3, in microglia in human hippocampal brain sections, and counted more Plin2+ Iba1+ microglia in aged than in young individuals (Fig. 1g).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > Microglia accumulate lipid droplets in the aging brain
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cells with high CellROX fluorescence were often loaded with lipid droplets (Fig. 5g).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM produce high levels of ROS and show excessive release of pro-inflammatory cytokines
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, Triacsin C increased Zymosan phagocytosis in LPS-treated cells (Fig. 4h,i).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM have phagocytosis deficits
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, the CellROX signal was twofold increased in LD-hi compared to LD-lo microglia (Fig. 5d–e), suggesting that the elevated ROS levels in aged microglia might be specifically driven by the increased ROS generation of LDAM”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM produce high levels of ROS and show excessive release of pro-inflammatory cytokines
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, we frequently detected BODIPY+ Iba1+ microglia in the thalamus and occasionally also in the cortex and corpus callosum in GRN−/− mice (Extended Data Figure 5).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > GRN−/− mice contain high numbers of lipid droplet-accumulating microglia which have functional impairments and a transcriptional signature similar to LDAM
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 51
- Probably not a substantial claim. 42
- The quote only partly states this claim. 1
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the aging brain and in neurodegeneration, microglia lose their homeostatic molecular signature and show profound functional impairments, such as increased production of pro-inflammatory cytokines, elevated generation of reactive oxygen species (ROS) and build-up of dysfunctional lysosomal deposits indicative of impaired phagocytosis2.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Partly supportedcites [2] Mosher, K. I. & Wyss-Coray, T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem. Pharmacol. 88, 594–604 (2014). sourceExperimental — accuracy not yet measured
Section 4.4 reports generally increased pro-inflammatory cytokine release from aged microglia, altered marker expression, and increased oxidative stress with aging. Section 4.5 reports lysosomal inclusions in aged microglia, but says impaired degradation is a possible interpretation and that age-related effects on phagocytosis remain poorly defined. The source therefore supports the broad pattern, but not a definitive loss of a homeostatic molecular signature or the claim that the deposits establish impaired phagocytosis. (LLM, conf=0.87)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another characteristic of aged microglia is the increased production of inflammatory cytokines such as TNF-α, IL-1β and IL-6 under baseline conditions and excessive cytokine release upon immune challenge2.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM produce high levels of ROS and show excessive release of pro-inflammatory cytokines
What the sources say
- Partly supportedcites [2] Mosher, K. I. & Wyss-Coray, T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem. Pharmacol. 88, 594–604 (2014). sourceExperimental — accuracy not yet measured
Section 4.4 (page unavailable) says proinflammatory cytokine production and release by aged microglia are generally increased, and identifies TNF-α, IL-1β and IL-6 as markers often elevated in aged mice. But it says secretion depends on the stimulant and notes studies finding no age-related activation differences without pathological insults; it does not establish increased production of all three under baseline conditions or consistently excessive release upon immune challenge. The Conclusion (page unavailable) presents over-reactivity to additional stimuli as a possibility. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Impaired phagocytosis is considered a hallmark of microglia aging2.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM have phagocytosis deficits
What the sources say
- Supportedcites [2] Mosher, K. I. & Wyss-Coray, T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem. Pharmacol. 88, 594–604 (2014). source
The Conclusion explicitly lists impaired phagocytosis among six proposed “hallmarks of microglial aging.” This directly supports the citing sentence’s characterization. (LLM, conf=0.94)
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Of note, we used an optimized microglia isolation strategy that uses mechanical tissue homogenization instead of enzymatic digestion, which keeps microglia largely in a non-activated state and therefore prevents unwanted bias towards an activated pro-inflammatory signature19.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > Lipid droplet-rich microglia have a unique transcriptome signature that is associated with cellular dysfunctions
What the sources say
- Could not verifycites [19] Yu, Y., Ramachandran, P. V. & Wang, M. C. Shedding new light on lipid functions with CARS and SRS microscopy. Biochim. Biophys. Acta 1841, 1120–1129 (2014). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Lipid droplets were also induced in LPS-treated mouse hippocampal slice cultures and in the N9 microglia cell line15,16.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Could not verifycites [15] Shimabukuro, M. K. et al. Lipid-laden cells differentially distributed in the aging brain are functionally active and correspond to distinct phenotypes. Sci. Rep. 6, 23795 (2016). sourceExperimental — accuracy not yet measured
The Results section describes lipid-laden cells in brain tissue from aging mice, and the Methods describe staining brain sections. Searches for LPS-treated hippocampal slice cultures and the N9 microglia cell line found no passage addressing either experiment in our copy. (LLM, conf=0.74)
- Supportedcites [16] Chang, P. K., Khatchadourian, A., McKinney, R. A. & Maysinger, D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J. Neuroinflammation 12, 34 (2015). source
The Results (Figure 1 and accompanying text) report increased numbers of large lipid bodies after LPS treatment in both mouse hippocampal slice cultures and N9 microglia. In the slices, the total number of lipid bodies decreased, so the reported induction specifically concerns large lipid bodies. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“GRN mutations are linked to the development of frontotemporal dementia (FTD)34, and GRN−/− mice are used as a model for FTD and are characterized by microglial changes, neuroinflammation, and cognitive deficits36.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > GRN−/− mice contain high numbers of lipid droplet-accumulating microglia which have functional impairments and a transcriptional signature similar to LDAM
What the sources say
- Could not verifycites [34] Liu, P. et al. S113R mutation in SLC33A1 leads to neurodegeneration and augmented BMP signaling in a mouse model. Dis. Model. Mech. 10, 53–62 (2017). sourceExperimental — accuracy not yet measured
Citation 36 is attached to the claim about GRN−/− mice. The Results and Discussion passages concern Slc33a1-mutant mice and hereditary spastic paraplegia; searches for GRN, progranulin, FTD, microglial changes, neuroinflammation, and cognitive deficits found no passage addressing the GRN−/− model. The separate claim that GRN mutations are linked to FTD is attached to citation 34, not this source. (LLM, conf=0.76)
- Could not verifycites [36] Tsika, E. et al. Parkinson’s disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Hum. Mol. Genet. 23, 4621–4638 (2014). sourceExperimental — accuracy not yet measured
Citation 36 is attached to the claim about GRN−/− mice. The Discussion describes a rat model of VPS35-associated Parkinson’s disease, not a GRN−/− mouse model of FTD. Searches for GRN, FTD, microglial changes, neuroinflammation, and cognitive deficits found no passage addressing that claim. (LLM, conf=0.78)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Oil-red-O positive “lipid-laden” cells, including neurons, astrocytes, ependymal cells and Iba1+ cells have recently been reported in mice and shown to increase with age 14.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Partly supportedcites [14] Liu, L. et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell 160, 177–190 (2015). sourceExperimental — accuracy not yet measured
The Results section on Ndufs4−/− mice reports lipid droplets in mouse brain cells bearing astrocyte and microglia markers. It does not report Oil-red-O staining or lipid-laden ependymal cells or neurons. Nor does it show a general increase with age: droplets progressively disappeared in the vestibular nucleus as the mutant mice aged, although they persisted in the olfactory bulb (page unavailable in our copy). (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Surprisingly, lipid droplets have not been studied functionally in brain myeloid cells in humans or vertebrates, and less than a handful of papers report the histological presence of lipid droplets in human brains11,12.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Could not verifycites [11] Childs, B. G. et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354, 472–477 (2016). sourceExperimental — accuracy not yet measured
The passages on atherosclerotic plaques (section labeled Abstract; page unavailable) describe lipid-loaded macrophage-like cells in mouse arteries, not brain myeloid cells. Searches for brain microglia, lipid droplets, and human-brain histology found no passage addressing whether functional studies exist or how many papers report their histological presence. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [12] Castejon, O. J., Castellano, A., Arismendi, G. J. & Medina, Z. The inflammatory reaction in human traumatic oedematous cerebral cortex. J. Submicrosc. Cytol. Pathol. 37, 43–52 (2005).
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“This is of particular interest because it has been shown that in GRN−/− mice, neuroinflammation is most pronounced in the thalamus40.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Could not verifycites [40] Rambold, A. S., Cohen, S. & Lippincott-Schwartz, J. Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. Dev. Cell 32, 678–692 (2015). sourceExperimental — accuracy not yet measured
The Results passages concern fatty-acid trafficking in starved cells and mitochondrial-fusion-deficient cells, not neuroinflammation in GRN−/− mice. Searches for GRN−/− mice, thalamus, and progranulin-related neuroinflammation found no passage addressing the claim; page numbers were unavailable. (LLM, conf=0.78)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Excitingly, knockout of GRN, which causes frontotemporal dementia in people with loss of function mutations in this gene34, resulted in severe accumulation of lipid droplets in microglia in vivo.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
What the sources say
- Could not verifycites [34] Liu, P. et al. S113R mutation in SLC33A1 leads to neurodegeneration and augmented BMP signaling in a mouse model. Dis. Model. Mech. 10, 53–62 (2017). sourceExperimental — accuracy not yet measured
The Results and Discussion passages concern SLC33A1 mutations, hereditary spastic paraplegia, and BMP signaling, not GRN. Searches for GRN, progranulin, frontotemporal dementia, and loss-of-function mutations found no passage in our copy addressing the attributed claim. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Lastly, there is emerging evidence that lysosomes become dysfunctional in aged microglia2.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > Role of lipid droplets in the LDAM functional phenotype
What the sources say
- Partly supportedcites [2] Mosher, K. I. & Wyss-Coray, T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem. Pharmacol. 88, 594–604 (2014). sourceExperimental — accuracy not yet measured
Section 4.5 (Phagocytosis; page unavailable) reports lysosomal inclusions in aged rodent microglia and says these may indicate impaired degradation of ingested material. That is emerging evidence consistent with the claim, but the paper does not establish that the lysosomes themselves become dysfunctional. (LLM, conf=0.82)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Besides inflammation, metabolic changes towards increased fatty acid production have been reported to cause lipid droplet formation in immune cells9 and also in cancer cells41.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Not checked — no full text of the sourcecites [9] Bozza, P. T. & Viola, J. P. Lipid droplets in inflammation and cancer. Prostaglandins Leukot. Essent Fatty Acids 82, 243–250 (2010). source
- Could not verifycites [41] Ghoshal, N., Dearborn, J. T., Wozniak, D. F. & Cairns, N. J. Core features of frontotemporal dementia recapitulated in progranulin knockout mice. Neurobiol. Dis. 45, 395–408 (2012). sourceExperimental — accuracy not yet measured
The Results section on microglial activation reports increased microglia/macrophages in progranulin-knockout mice, and the ubiquitin-immunoreactivity section mentions a few foamy macrophages. Neither passage addresses increased fatty acid production or lipid droplet formation in immune cells. Searches for those terms found no supporting passage; the cancer-cell portion is attached to a different citation. (LLM, conf=0.75)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Every source the paper cites for this claim was checked and supports it.
In the paper
“For example, lipid droplets in microglia have been detected in adult mice after induction of ROS by rotenone13, in hippocampal slice culture from P6–8 mice upon treatment with LPS, and in LPS-treated cells of the microglia-like cell line N916.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Supportedcites [16] Chang, P. K., Khatchadourian, A., McKinney, R. A. & Maysinger, D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J. Neuroinflammation 12, 34 (2015). source
The Results report lipid bodies in LPS-treated N9 microglia and quantify an increase in large lipid bodies. The Figure 1 caption also describes lipid-body formation in LPS-treated N9 cells. These passages support the portion of the citing sentence attributed to this paper. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, expression of ACLY, a key enzyme in the shift from the TCA cycle to lipid formation that has been shown to cause lipid droplet accumulation42, is significantly higher in LDAM than in microglia without lipid droplets.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Partly supportedcites [42] Currie, E., Schulze, A., Zechner, R., Walther, T. C. & Farese, R. V. Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 18, 153–161 (2013). sourceExperimental — accuracy not yet measured
The ACLY subsection of “Blocking Fatty Acid Synthesis” says ACLY links glucose metabolism to fatty-acid synthesis and that knocking it down reduces conversion of glucose to lipid. The “Diverting Fatty Acids to Storage” subsection discusses lipid droplets, but does not say ACLY causes their accumulation. Page numbers are unavailable in our copy. (LLM, conf=0.87)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recently, it has been shown that several subsets of microglia with unique molecular and functional phenotypes exist in the healthy, aged, and degenerating brain3–5.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
What the sources say
- Partly supportedcites [3] Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290.e17 (2017). sourceExperimental — accuracy not yet measured
The Results identify distinct microglial states in an Alzheimer’s mouse model, with altered gene expression and phagocytic characteristics; they also compare these cells with wild-type controls. The paper does not establish several distinct subsets across healthy, normally aged, and degenerating brains: its disease-associated states were observed in the AD model, not the wild-type controls. No page numbers are available in our copy. (LLM, conf=0.86)
- Supportedcites [4] Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566–581.e9 (2017). source
The Results section on disease-associated microglia distinguishes homeostatic adult microglia from the MGnD phenotype during aging and disease progression. The Results section on neuritic Aβ plaques identifies three microglial subsets with different molecular markers and plaque associations; the Discussion also describes phagocytosis-associated phenotypic changes. The copy provides no page numbers for these passages. (LLM, conf=0.89)
- Partly supportedcites [5] Li, Q. et al. Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing. Neuron 101, 207–223.e10 (2019). sourceExperimental — accuracy not yet measured
The Results describe distinct microglial populations in the healthy developing mouse brain, and the Discussion compares one of them with disease-associated microglia. But the paper does not establish several distinct subsets in aged brains; its Discussion instead reports little transcriptomic variation among classical adult microglia. The claim extends the paper’s findings beyond the populations it studied. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Lipid droplets can form due to various environmental and cellular conditions, including elevated concentrations of extracellular lipids, inflammatory events, increased ROS levels and intracellular metabolic changes38,39.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Partly supportedcites [38] Vieira-de-Abreu, A. et al. Cross-talk between macrophage migration inhibitory factor and eotaxin in allergic eosinophil activation forms leukotriene C(4)-synthesizing lipid bodies. Am. J. Respir. Cell Mol. Biol. 44, 509–516 (2011). sourceExperimental — accuracy not yet measured
The copy’s Abstract reports lipid-droplet formation during allergic pulmonary inflammation and after inflammatory MIF stimulation of eosinophils. It does not address elevated extracellular lipids, increased ROS, or intracellular metabolic changes as causes; searches for those terms returned no supporting passage. No page number is available in the indexed copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [39] Hu, X., Xu, B. & Ge, W. The role of lipid bodies in the microglial aging process and related diseases. Neurochem. Res. 42, 3140–3148 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“This is in line with findings which have shown that lipid droplet containing immune cells in the periphery are detrimental, including foamy macrophages in atherosclerosis10 or lipid droplet-rich eosinophils in experimental models of allergy37.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What is the role of LDAM in the aging brain?
What the sources say
- Not checked — no full text of the sourcecites [10] den Brok, M. H., Raaijmakers, T. K., Collado-Camps, E. & Adema, G. J. Lipid droplets as immune modulators in myeloid cells. Trends Immunol. 39, 380–392 (2018). source
- Could not verifycites [37] Yin, F. et al. Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia. FASEB J. 24, 4639–4647 (2010). sourceExperimental — accuracy not yet measured
The citation is attached to the example of lipid droplet-rich eosinophils in experimental allergy models. Our copy’s Discussion addresses inflammation and immune responses in progranulin-deficient mice, but searches for eosinophils, lipid droplets, and allergy found no passage addressing that example. Page numbers were not available in the indexed copy. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Likewise, LDAM showed only low overlap with the transcriptome of recently identified “lipid-associated macrophages” from mouse and human adipose tissue, a cell population that controls metabolic homeostasis in a TREM2 dependent manner and is transcriptionally similar to DAM48.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
What the sources say
- Could not verifycites [48] Chandak, P. G. et al. Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J. Biol. Chem. 285, 20192–20201 (2010). sourceExperimental — accuracy not yet measured
The Results discuss ATGL expression in macrophages and foam cells, while the Introduction and Discussion focus on lipid storage and phagocytosis (page numbers unavailable). Searches for TREM2-dependent metabolic homeostasis and transcriptional similarity to DAM found no passage addressing either claim. (LLM, conf=0.75)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Almost 2,000 genes were differentially expressed between LD-hi and LD-lo microglia (Fig. 7h) and linked to metabolic processes and cellular response to stress (Fig. 7i), pathways that are also enriched in LDAM (Fig, 2e, Extended Data Fig. 2b).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > GRN−/− mice contain high numbers of lipid droplet-accumulating microglia which have functional impairments and a transcriptional signature similar to LDAM
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pathway Analysis of differentially expressed genes revealed Phagosome maturation and Production of NO and ROS, two key functions of microglia that become dysregulated with age, as the most significant pathways associated with LD-hi microglia (Fig. 2e).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > Lipid droplet-rich microglia have a unique transcriptome signature that is associated with cellular dysfunctions
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lipidomics analysis revealed that lipid droplets from the whole hippocampus and from aged microglia show a nearly identical lipid distribution and are mainly composed of glycerolipids (hippocampus: 41.3%; microglia: 44.4%), while cholesteryl esters were almost absent (hippocampus: 1.1%; microglia: 0.7%) (Fig. 1k).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > Microglia accumulate lipid droplets in the aging brain
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We used flow cytometry to measure ROS levels and found significantly increased ROS generation in BV2 cells with sgRNAs targeting GRN and SLC33A1 cells under baseline conditions and in SLC33A1 sgRNA expressing cells upon LPS treatment (Fig. 6h).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > CRISPR-Cas9 screen identifies genes linked to neurodegeneration as genetic regulators of lipid droplet formation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Production of NO and ROS was the second most significantly regulated pathway in LDAM (Fig. 2e) with over 90% of the differentially expressed genes increased (Fig. 5a).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM produce high levels of ROS and show excessive release of pro-inflammatory cytokines
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, we observed characteristic lipid droplets in aged but rarely in young microglia and they were frequently adjacent to dense lysosomal material (Fig. 1a).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > Microglia accumulate lipid droplets in the aging brain
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Unsupervised cluster analysis segregated LD-lo from LD-hi microglia and revealed prominent differences between their transcriptome with 692 significantly differentially expressed genes (Fig. 2c,d).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > Lipid droplet-rich microglia have a unique transcriptome signature that is associated with cellular dysfunctions
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that microglia in the hippocampus of GRN−/− mice contained high numbers of lipid droplets, resulting in a twofold higher percentage of BODIPY+ microglia and twice as many lipid droplets per cell in GRN−/− mice compared with wild type littermates (Fig. 7a–c).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > GRN−/− mice contain high numbers of lipid droplet-accumulating microglia which have functional impairments and a transcriptional signature similar to LDAM
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, lipid droplets from BV2 cells and from aged microglia showed a similar chain length distribution of TAG-associated fatty acids with peaks at 38:2 and 44:5, while liver lipid droplets had a shift towards longer TAG chain fatty acids with a peak at 52:2 carbon atoms, which is in agreement with previous reports26 (Fig. 3g,h).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > The innate TLR4 ligand LPS induces lipid droplet formation in microglia
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, phagosome maturation was the top regulated pathway associated with the transcriptome of LDAM (Fig. 2e), characterized by upregulation of endosomal and lysosomal genes (Fig. 4a) and increased immunoreactivity for the lysosome-associated protein CD68 in BODIPY+ microglia in the hippocampus of aged mice (Fig. 4b,c).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM have phagocytosis deficits
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that although only nine common genes were differentially expressed in all three data sets (one of them was the lipid droplet specific gene PLIN3), the directionality of expression changes of LDAM genes was remarkably similar for all groups and almost identical for LDAM and LD-hi GRN−/− microglia (Fig. 7l,m; Extended Data Figure 6).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > GRN−/− mice contain high numbers of lipid droplet-accumulating microglia which have functional impairments and a transcriptional signature similar to LDAM
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lipid droplets were primarily found in microglia but not in other cell types.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > Microglia accumulate lipid droplets in the aging brain
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, they had a highly similar overall lipid content and a similar composition of neutral lipids, with low amounts of cholesteryl esters but high levels of glycerolipids (MAG, TAG).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > The innate TLR4 ligand LPS induces lipid droplet formation in microglia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, sgRNAs targeting GRN and SLC33A1 induced significant defects in phagocytosis and increased ROS production in BV2 cells, hence recapitulating the functional impairments of LDAM.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, we found that LPS treatment, which provokes an acute inflammatory response in the brain, led to lipid droplet formation in hippocampal microglia in young mice in vivo and in the microglia cell line BV2 in vitro.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We did not find ultrastructural evidence for cholesterol crystals, and lipidomics analysis revealed that these lipid droplets contained mainly glycerolipids and only low amounts of cholesteryl ester.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Indeed, sgRNAs targeting these genes were able to increase (SLC33A1, GRN, VPS35) and decrease (SNX17) lipid droplet load in microglial BV2 cells.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Intriguingly, we observed that LDAM contain high numbers of lysosomes, and moreover, these lysosomes accumulate in close contact to lipid droplets.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > Role of lipid droplets in the LDAM functional phenotype
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These lipid droplet rich microglia in GRN−/− mice show a similar transcriptome signature and the same functional impairments as LDAM.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that although only nine common genes were differentially expressed in all three data sets (one of them was the lipid droplet specific gene PLIN3), the directionality of expression changes of LDAM genes was remarkably similar for all groups and almost identical for LDAM and LD-hi GRN−/− microglia (Fig. 7l,m; Extended Data Figure 6).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > GRN−/− mice contain high numbers of lipid droplet-accumulating microglia which have functional impairments and a transcriptional signature similar to LDAM
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BODIPY+/Iba1+ cells were frequently found in the thalamus and were detected to a lesser extent in cortex and corpus callosum.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lipid droplet accumulating microglia are abundant in the hippocampus but rare in other brain regions of aged mice.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
plaincorrelationaln = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Paired dot plot showing FPKM values of LD-lo and LD-hi microglia for ApoE (paired Student’s t-test; P= 0.423).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Since triacylglycerides (TAG) are a major component of lipid droplets in LDAM, it is possible that lipid droplet accumulation in GRN deficient microglia contributes to elevated TAG levels in brains lacking GRN.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pie charts showing that the lipid composition of lipid droplets from young and aged microglia is highly similar, but differs between young and aged liver tissue.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“LPS treatment induces lipid droplet formation in microglia and in BV2 cells.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
plaindirectn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Here, lipid droplets are production and storage sites for eicosanoids and inflammatory cytokines, and are further involved in antigen presentation and pathogen clearance9.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Not checked — no full text of the sourcecites [9] Bozza, P. T. & Viola, J. P. Lipid droplets in inflammation and cancer. Prostaglandins Leukot. Essent Fatty Acids 82, 243–250 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In particular, lipid droplets, which are lipid storing organelles that contain neutral lipids such as glycerolipids and cholesterol, are increasingly accepted as structural markers of inflammation8.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Not checked — no full text of the sourcecites [8] Fowler, S. D., Mayer, E. P. & Greenspan, P. Foam cells and atherogenesis. Ann. NY Acad. Sci. 454, 79–90 (1985). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
In the paper
“Myeloid cells form lipid droplets in response to inflammation and stress, including the aforementioned macrophages in atherosclerotic lesions, leukocytes in inflammatory arthritis, and eosinophils in allergic inflammation.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Not checked — no full text of the sourcecites [9] Bozza, P. T. & Viola, J. P. Lipid droplets in inflammation and cancer. Prostaglandins Leukot. Essent Fatty Acids 82, 243–250 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Collectively, these data suggest that lipid droplet-rich microglia have phagocytosis deficits and that increased lipid storage is associated with impaired phagocytosis.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM have phagocytosis deficits
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These findings suggest that LDAM are in a primed activation state that becomes hyperactivated upon stimulation with LPS.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM produce high levels of ROS and show excessive release of pro-inflammatory cytokines
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings demonstrate that LDAM have elevated concentrations of ROS and suggest that lipid droplets mediate LPS-induced ROS generation.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > LDAM produce high levels of ROS and show excessive release of pro-inflammatory cytokines
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Importantly, lipid-droplet rich foam cells in atherosclerosis show hallmarks of senescent cells and they seem deleterious at all stages of disease10.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Not checked — no full text of the sourcecites [10] den Brok, M. H., Raaijmakers, T. K., Collado-Camps, E. & Adema, G. J. Lipid droplets as immune modulators in myeloid cells. Trends Immunol. 39, 380–392 (2018). source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“That they may have important functions in disease has recently been suggested in a drosophila model where lipid droplet formation has been reported in glia at the onset of neurodegeneration13.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
What the sources say
- Not checked — no full text of the sourcecites [13] Lee, S. C., Moore, G. R., Golenwsky, G. & Raine, C. S. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropathol. Exp. Neurol. 49, 122–136 (1990). source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings demonstrate that LPS triggers lipid droplet formation in microglia in vitro and in vivo, and lipid droplet containing microglia in young LPS-treated mice show a transcriptional signature that partially overlaps with LDAM.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > The innate TLR4 ligand LPS induces lipid droplet formation in microglia
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, LPS-induced lipid droplets in BV2 cells are highly similar to lipid droplets in aged microglia, thus making this in vitro assay a useful model to study lipid droplets in LDAM.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > The innate TLR4 ligand LPS induces lipid droplet formation in microglia
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, these data suggest that lipid droplet-containing aged microglia show transcriptional changes of genes related to key microglia functions such as phagocytosis, ROS production and immune signaling, yet they have a unique transcriptome signature that is distinct from previously described microglia states observed in aging and neurodegeneration.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > Lipid droplet-rich microglia have a unique transcriptome signature that is associated with cellular dysfunctions
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a drosophila model for neurodegeneration13, lipid droplets in glia form due to an APOE dependent transfer of lipids from neurons to glia.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Not checked — no full text of the sourcecites [13] Lee, S. C., Moore, G. R., Golenwsky, G. & Raine, C. S. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropathol. Exp. Neurol. 49, 122–136 (1990). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“This finding is in line with a previous report which observed that at the sites of atherosclerotic lesions, lipid droplet rich foamy macrophages show decreased phagocytosis activity compared to macrophages without lipid droplets46.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > Role of lipid droplets in the LDAM functional phenotype
What the sources say
- Not checked — no full text of the sourcecites [46] Nadjar, A. Role of metabolic programming in the modulation of microglia phagocytosis by lipids. Prostaglandins Leukot. Essent. Fatty Acids 135, 63–73 (2018). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings validate the in vivo relevance of our in vitro CRISPR screen and confirm that microglia from GRN−/− mice contain lipid droplets.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > GRN−/− mice contain high numbers of lipid droplet-accumulating microglia which have functional impairments and a transcriptional signature similar to LDAM
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings indicate that LDAM represent a dysfunctional and pro-inflammatory microglia state in the aging brain, and further suggest that LDAM might contribute to neurodegenerative diseases.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Introduction
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this study, we identify a novel, lipid droplet accumulating microglia (LDAM) state in the aging brain and show that LDAM are characterized by a unique transcriptional signature, severe functional deficits and a pro-inflammatory phenotype.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“LDAM and DAM also show different functional phenotypes; while DAM are actively phagocytic populations, LDAM are severely impaired in this function.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: DAM are actively phagocytic populations.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Remarkably, LD-hi microglia from GRN−/− mice and LDAM in aging have similar functional and transcriptional phenotypes, suggesting that lipid droplet containing GRN−/− microglia share the LDAM state.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Results > GRN−/− mice contain high numbers of lipid droplet-accumulating microglia which have functional impairments and a transcriptional signature similar to LDAM
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the brain, a protective role has been reported for lipid droplets in glia in a drosophila model for neurodegeneration13.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What is the role of LDAM in the aging brain?
What the sources say
- Not checked — no full text of the sourcecites [13] Lee, S. C., Moore, G. R., Golenwsky, G. & Raine, C. S. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropathol. Exp. Neurol. 49, 122–136 (1990). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“However, lipid droplets have also been correlated with beneficial functions, such as improved host defense and antigen cross presentation in myeloid cells9.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What is the role of LDAM in the aging brain?
What the sources say
- Not checked — no full text of the sourcecites [9] Bozza, P. T. & Viola, J. P. Lipid droplets in inflammation and cancer. Prostaglandins Leukot. Essent Fatty Acids 82, 243–250 (2010). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In peripheral immune cells, lipid droplets form often as a response to inflammation and stress9.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Not checked — no full text of the sourcecites [9] Bozza, P. T. & Viola, J. P. Lipid droplets in inflammation and cancer. Prostaglandins Leukot. Essent Fatty Acids 82, 243–250 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“For example, lipid droplets in microglia have been detected in adult mice after induction of ROS by rotenone13, in hippocampal slice culture from P6–8 mice upon treatment with LPS, and in LPS-treated cells of the microglia-like cell line N916.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Not checked — no full text of the sourcecites [13] Lee, S. C., Moore, G. R., Golenwsky, G. & Raine, C. S. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropathol. Exp. Neurol. 49, 122–136 (1990). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Cholesterol accumulation has recently been observed in phagocytes in an EAE demyelination model in aged mice as a result of excessive uptake of myelin debris43.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What causes lipid droplet formation in LDAM?
What the sources say
- Not checked — no full text of the sourcecites [43] Burke, A. C. & Huff, M. W. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia. Curr. Opin. Lipidol. 28, 193–200 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“In this context, a study in macrophages has shown that engulfment of cellular debris relies on the availability of free fatty acids, which are released upon degradation of lipid droplets, thus linking effective lysis of lipid droplets with successful phagocytosis47.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > Role of lipid droplets in the LDAM functional phenotype
What the sources say
- Not checked — no full text of the sourcecites [47] Chinetti-Gbaguidi, G. et al. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. Circ. Res. 108, 985–995 (2011). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Microglia in the LDAM state, which account for more than 50% of all microglia in the aged hippocampus, but not microglia without lipid droplets, show typical age-related functional impairments and a primed phenotype, suggesting that LDAM may be the primary detrimental microglia state in the aging brain.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > What is the role of LDAM in the aging brain?
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, we show that LDAM demonstrate a novel state of microglia with a unique transcriptional signature and functional impairments in the aging brain, and we identified lipid droplet containing microglia in a GRN−/− model for chronic neuroinflammation, and in an LPS-induced acutely inflamed brain milieu.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Discussion > LDAM in neurodegeneration
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Data were replicated in at least three independent experiments.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The quote only partly states this claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All samples used were obtained from individuals without any neurological or psychiatric diagnoses.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Human post-mortem brain tissue
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Data in a-b were replicated in at least two independent experiments.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Data collection was randomized for all experiments.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Statistical analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For quantification of BODIPY+ microglia, of CD68hi microglia, of BODIPY+ lipid droplet numbers and of lipid droplet size, analyses were performed blinded on coded slides.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Quantitative analysis of immunohistological data
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“No sample-size calculations were performed.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Statistical analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Further, sample sizes were chosen based on prior literature using similar experimental paradigms.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Statistical analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Six randomly selected visual fields per animal were photographed using a confocal scanning laser microscope (LSM 700, Zeiss) with LSM software (ZEN 2011) and used for quantitative analysis.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Quantitative analysis of immunohistological data
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For quantification of CARS signal in microglia, 20 randomly selected microglia in the dentate gyrus per animal were imaged.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > CARS Imaging
plainn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“False discovery rate was estimated using Benjamini and Hochberg approach (Benjamini and Hochberg, 1995).”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > RNA-seq differential expression
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Experimenters were blinded for imaging and data analysis.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Statistical analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All samples passed a quality control threshold (RIN ≥ 9.0) to proceed to library preparations and RNAseq.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > RNA isolation and library preparation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Sample size was determined to be adequate based on the magnitude and consistency of measurable differences between groups.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Statistical analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“sgRNA infection was confirmed by flow cytometry, which indicated >90% of cells expressed the mCherry reporter.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > CRISPR-Cas9 Screen
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
Demyelination is a characteristic of brain aging.
“Because demyelination is a characteristic of brain aging, we analyzed the cholesterol content of lipid droplets in LDAM.”
The paper relies on this without support.
DAM are actively phagocytic populations.
“LDAM and DAM also show different functional phenotypes; while DAM are actively phagocytic populations, LDAM are severely impaired in this function.”
The paper relies on this without support.
TREM2 and APOE are key genes involved in the progression of neurodegeneration and are upregulated in DAM and MGnD.
“Furthermore, TREM2 and APOE, two key genes involved in the progression of neurodegeneration that are upregulated in DAM and MGnD, are not regulated in LDAM.”
The paper relies on this without support.
GRN−/− mice is a model for frontotemporal dementia characterized by severe chronic neuroinflammation.
“Furthermore, we found lipid droplet containing microglia in GRN−/− mice, a model for frontotemporal dementia that is characterized by severe chronic neuroinflammation.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the accumulation of which is considered a marker of inflammation in microglia during aging and Alzheimer’s disease32–35”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, LDs—cellular organelles containing lipids such as glycerolipids and cholesterol—were recently found to have important roles in ageing and Alzheimer's disease (AD)10–15.”
From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our results align with previously reported TG increases in LDAMs10 and APOE4-associated LDs19, further supporting our observed PICALM-risk-allele-associated LD accumulation in iMGs.”
From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, three known LD suppressor genes (SLC33A1, MCOLN1 and GRN)10 all exhibited reduced expression in LOAD-risk-allele iMGs (Fig. 5d), two of which are related to lysosomal function: MCOLN1 is a ROS sensor in lysosomes regulating autophagy49, and GRN encodes the lysosomal protein progranulin related to neurodegenerative diseases50.”
From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, proper regulation of lipid metabolism is essential to support these functions [20].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [20]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, phagocytic deficits in LDAM were observed, in line with defective conversion of microglia to the protective DAM phenotype [20]”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and lipid droplets have also been identified in aged/pathological microglia, pointing towards a role for lipid accumulation in AD [20].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, we and others (11, 13, 39) have observed that excessive LD accumulation within microglia led to a decline in their phagocytic activity, potentially reducing the efficiency of Aβ clearance in the AD brain.”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In relation to LD content, we and others have revealed the presence of more GLs in aged and diseased microglia (11), while the macroglia encountered in ischemic stroke are characterized by high cholesterol levels (63).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LD accumulation in macrophages can elevate their ROS production (9, 11), promoting neurovascular dysfunction (67).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these subsets, LDAM have been given much attention due to their sustained activation, impaired phagocytosis and surveillance, and autophagy dysregulation [26–28].”
From HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brain, LDs accumulate in glial cells upon neuronal oxidative stress and during aging (Liu et al., 2015; Marschallinger et al., 2020)”
From ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism (2021) · cites this paper as Marschallinger et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulation of neutral lipids, particularly cholesteryl esters (CE) and triacylglycerol (TAG) stored as lipids droplets (LD), is found in aged and AD brains [4–8].”
From Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipid accumulation in glia is linked to enhanced inflammatory responses and, thus, could significantly promote neurodegeneration in AD and other neurodegenerative disorders.”
From Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipid accumulation in glia is associated with increased oxidative stress and neuroinflammatory responses and, thus, may promote neurodegeneration.”
From Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oleic acid was incorporated mainly into TAG and only marginally into cholesteryl ester pools (Figures S4B and S4C; Marschallinger et al., 2020).”
From Isoform- and cell-state-specific lipidation of ApoE in astrocytes (2022) · cites this paper as Marschallinger et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent work in microglial biology studying aging and neurodegeneration has identified a population of lipid-droplet-accumulating microglia (LDAM), which display impaired phagocytosis and increased reactive oxygen species (ROS) production (Marschallinger et al., 2020).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Marschallinger et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“As seen in mouse microglia10, we further confirmed that LD accumulation influences ROS levels in iMGs by using TrC to block LD formation (Extended Data Fig. 7f–i).”
From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Like in mouse microglia10, there was an inverse relationship between BODIPY+ and Aβ–pHrodo+ signals in iMGs, and TrC treatment of the LOAD-risk-allele iMGs shifted the proportions of cells with varying BODIPY/pHrodo combinations to resemble non-risk iMGs (Extended Data Fig. 12d).”
From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Treating iMGs with triacsin C (TrC), an inhibitor of long-chain acyl-CoA synthetase that reduces LD formation10,18,19,39,40, effectively decreased BODIPY-labelled LDs (Extended Data Fig. 7e–i).”
From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Aged mouse microglia accumulate LDs and exhibit a dysfunctional microglial state termed LD-accumulating microglia (LDAM)5”
From APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia (2024) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“These results are similar to recent reports describing mouse LDAM that have a dysfunctional and inflammatory microglial state5.”
From APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia (2024) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“changes in microglial lipid content can also affect their state and function18,19,20,21”
From Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Inflammatory triggers like lipopolysaccharide (LPS)35,19, fatty acids36, and aging20 promote LD accumulation in primary microglial cells and cell lines.”
From Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“LD-laden microglia found in the aged brain also demonstrated phagocytic deficits20”
From Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“RNA-seq analysis of Lipid Droplet Accumulating Microglia (LDAM) isolated from aged mice revealed there are no changes in TREM2 expression in this cell type [20].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Lipid-droplet accumulating microglia (LDAM) have been identified in aged brains of mice and classified as dysfunctional cells as they exhibit defective phagocytic activity and show increased production of pro-inflammatory cytokines and reactive oxygen species (ROS) (11)”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Lipid-droplet accumulating microglia (LDAM) have been identified in aged brains of mice and classified as dysfunctional cells as they exhibit defective phagocytic activity and show increased production of pro-inflammatory cytokines and reactive oxygen species (ROS) (11)”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Many studies have demonstrated a phagocytosis defect associated with LD accumulation in microglia (11, 13).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“For instance, we confirmed the findings of Marschallinger et al. by showing that LDAM numbers increased with age (11).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Comparable innate responses induced by lipopolysaccharide have been strongly linked to LD formation within microglia (11).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“A recent study highlighted close contact between LDs and lysosomes within microglia, suggesting that, in LDAM, lysosomes might be used for lipophagy rather than the degradation of phagocytosed material (11).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain.71”
From Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer’s disease (2024) · cites this paper as [71]
The cited source says what the claim attributes to it.
In the citing paper
“Aged microglia accumulate LDs and adopt a proinflammatory state (Marschallinger et al., 2020).”
From APOE traffics to astrocyte lipid droplets and modulates triglyceride saturation and droplet size (2024) · cites this paper as Marschallinger et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“Altered lipid droplet biology has been linked to both brain aging and neurodegenerative diseases10–24.”
From APOE genotypes differentially remodel the astrocytic lipid droplet proteome to shape lipid droplet dynamics (2026) · cites this paper as [18]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although filipin only stains free (unesterified) cholesterol, cellular cholesterol accumulation is associated with excess LD10,37,38.”
From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Cholesterol ester aggregates have been found in TREM2 KO and AD-variant human iPSC microglia”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredIn the citing paper
“In microglia, lipid droplets form in response to innate inflammation, ageing and neurodegeneration and are mediated by canonical pathways of microglial activation, such as p38 MAPK [161,162].”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [162]
In the citing paper
“Progranulin (GRN) was determined to be a genetic regulator of LDAM formation and loss-of-function mutations in GRN are a cause of frontotemporal dementia [162,165].”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [162]
In the citing paper
“Progranulin (GRN) was determined to be a genetic regulator of LDAM formation and loss-of-function mutations in GRN are a cause of frontotemporal dementia [162,165].”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [162]
In the citing paper
“We performed this labeling because Marschallinger et al. (2020) demonstrated that a novel, age‐associated, LD‐rich microglial cell, “LDAM,” exhibits an accumulation of dysfunctional lysosomal deposits, impaired phagocytosis, and release of pro‐inflammatory mediators.”
From LDL Cholesterol Modulates Astrocyte Metabolism, Lipid Handling, and Morphology: Evidence From In Vitro and In Vivo Models (2026) · cites this paper as Marschallinger et al. (2020)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Plasma treatment
“BV2 cells were treated for 18 hours with 5% plasma (preparation see Plasma collection) in DMEM +5% FBS.”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
“BV2 cells treated with 5% plasma from young (3-months) and aged (18-months) mice for 12 hours.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > METHOD DETAILS > Plasma collection
“Blood from young (2-month-old) and aged (18-month-old) wild type mice was collected”
§ Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain > Extended Data
“BV2 cells treated with 5% plasma from young (3-months) and aged (18-months) mice for 12 hours.”
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · cited 2×
“, 2013); DAM versus homeostatic microglia (Keren-Shaul et al. 2017), MGnD versus homeostatic microglia (Kraseman et al. 2017), and microglia clusters published by Li et al. (2019) and Hammond and colleagues (2019). For gene set comparisons, we generated lists for the published datasets by using a 4-fold change cutoff…”
BackgroundMethodAutophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“References 1 Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8, 752-758, doi:10.1038/nn1472 (2005). 2 Nimmerjahn, A.”
BackgroundInfluentialSelf-citationKrasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 1×
“For example, Keren-Shaul and co-workers(12) (2017) identified a protective, phagocytic microglia subtype (“DAM”) with the potential to restrict neurodegeneration, and Krasemann and colleagues(11) (2017) identified a dysfunctional, neurodegenerative microglia phenotype (“MGnD”).”
BackgroundThomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Hammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., et al. (2018) · doi:10.1101/406140 · Cited by 2,225 · cited 2×
“…in aging40, ALS41, and AD42, and of microglia subpopulations recently identified in development, aging and disease, including “disease-associated microglia” (DAM)12, “neurodegenerative microglia” (MGnD)11, and microglia clusters revealed by Li et al. (2019) and Hammond et al. (2019)14, 15.”
BackgroundInfluential
Cited by
Sorted by citations
Items 701–800 of 1,413
The interplay between lipid droplets and Parkinson's disease
Zhao, X., Gu, Y., Wang, J., Yi, Y., Zhang, Y.-Q., Shao, Q.-H., Liu, M., & Zhang, X. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167953 · Cited by 10
Basic Microglial Functions and How They Go Awry in Neurodegenerative Disease
McKinney, J. E., Bennett, M. L., & Bennett, F. C. (2026) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042624-114332 · Cited by 13
Negredo, P. N., You, J., Hauptschein, M., Schroer, A. B., Richard, D. J., Abhiraman, G. C., Tsai, A. P., Sun, E., Notarangelo, G., Ramirez-Matias, J., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.01.016 · Cited by 12
Self-citationFine-tuning of microglia polarization prevents diabetes-associated cerebral atherosclerosis
Zhu, X., Xing, P., Zhang, P., Zhang, M., Shen, H., Chen, L., Shen, F., Jiang, Y., Yuan, H., Zhang, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948457 · Cited by 9
“Interestingly, as a resident macrophage in the central nerve system, microglia play critical roles in the inflammatory events and act as neuroinflammatory intermediaries between lipid overload and neurodegeneration (10).”
BackgroundClickable Biomaterials for Modulating Neuroinflammation
Cornelison, R. C., & Fadel, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158496 · Cited by 10
Shirozu, N., Ohgidani, M., Hata, N., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41456-z · Cited by 9
“Another study suggested that reduced phagocytosis produces high levels of reactive oxygen species and secretion of inflammatory cytokines 40 .”
BackgroundRetinal ischemia-reperfusion injury induces intense lipid synthesis and remodeling
Wu, D., An, Q., Ji, H., et al. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149232 · Cited by 9
Shea, J. M., & Villeda, S. (2024) · eLife · doi:10.7554/elife.97671 · Cited by 18
Multi-omic Characterization of HIV Effects at Single Cell Level across Human Brain RegionsPreprint
Yang, J., Agrawal, K., Stanley, J. S., Li, R., Jacobs, N., Wang, H., Lu, C. F., Qu, R., Clarke, D., Chen, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.05.636707 · Cited by 10
Zou, F., Su, B., Leng, H., Xin, N., Jiang, S., Wei, D., Yang, M. J., Wang, Y., & Fan, H. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109523 · Cited by 8
Ma, H., Ou, Z., Alaeiilkhchi, N., Cheng, Y., Chen, K., Chen, J., Guo, R.-Q., He, M.-Y., Tang, S.-Y., Zhang, X., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02185-y · Cited by 12
“Hence, this new subtype was named LDAM [6].”
BackgroundMayo, F., González-Vinceiro, L., Hiraldo-González, L., Rodríguez-Gómez, F. D., Calle-Castillejo, C., Mayo, M., Netti, V. A., Ramírez‐Lorca, R., & Echevarrı́a, M. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00548-2 · Cited by 9
“2), against those of microglial populations described by other authors [34–36, 38–41, 70] leads us to conclude that the nature and presence of these CD11c + microglia are related to the mice’s neurodevelopment process, more than to a defence response against harm.”
BackgroundResultVolk, K. M., Rodriguez, A. S., Cartailler, J., Shrestha, S., Schleh, M. W., Schroeder, K. R., Valenti, A. M., Kramer, A. T., Harrison, F. E., & Hasty, A. H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03238-w · Cited by 9
Spatially heterogeneous lipid dysregulation in tuberculous meningitis
Kim, J., Spears, I., Erice, C., Kim, H., Porter, N. A., Tressler, C. M., & Tucker, E. W. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106721 · Cited by 8
“A study looking at aging brains found that lipid-droplet accumulation in microglia led to dysfunctional microglia with increased proinflammatory cytokines and oxidative stress and decreased phagocytosis (Marschallinger et al., 2020).”
BackgroundSelf-citationSenescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li, W., Xie, Y., Jia-Xin, M., Shu-Chao, G., & Li-Ping, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149480 · Cited by 11
Che, J., Wu, Y., Dong, J., Jiang, X., Li, Y., Chen, Y., & Zhang, J. (2025) · Glia · doi:10.1002/glia.70000 · Cited by 8
“Lipid- droplet-aggregating microglia (LDAM) exhibit functional defects in phagocytosis while producing high levels of reactive oxygen species and secreting proinflammatory cytokines (Marschallinger et al. 2020).”
ATP11B Modulates Microglial Lipid Metabolism and Alleviates Alzheimer's Disease Pathology
Zhang, Y., Zhang, S., Zhao, X., Wu, P., Ying, Y., Wu, L., Zhuang, J., Chen, Z., Chao, Y., Dong, X., et al. (2025) · MedComm · doi:10.1002/mco2.70139 · Cited by 10
“LDAM exhibits a distinctive transcriptional profile and gradually accumulates LDs, produces ROS, and releases proinflammatory factors as individuals age [10].”
Villacampa, N., Sarlus, H., Martorell, P., Bhalla, K., Castro‐Gomez, S., Vieira-Saecker, A. M. M., Slutzkin, I., Händler, K., Venegas, C., McManus, R. M., et al. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2506406 · Cited by 11
“Recent advances in transcriptomic profiling have identified new subpopulations of microglia and studied their role in aging (Marschallinger et al., 2020; O’Neil et al., 2018) and disease (Chiu et al., 2013; Keren-Shaul et al., 2017; Krasemann et al., 2017).”
Fan, X., Cao, S., Fang, Y., Zhu, L., & Wang, X. (2025) · Antioxidants · doi:10.3390/antiox14080918 · Cited by 8
Repopulation of microglia and its implications for CNS disorders: Insights from the single-cell era
Chen, C., Qiao, G., Tang, D., Xu, F., Dong, J., Zhang, J., & Jin, B. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107066 · Cited by 8
Li, S., Zhou, H., Zhao, G., Ding, W., Zhang, Y., Wang, Y., Li, F., Miao, Y., Sun, X., & Wang, Z. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01478-1 · Cited by 8
“Multiple assays can be used to quantify phagocytosis, among which the direct observation of ingested particles using an optical means or microscope is a valuable tool for estimating phagocytosis [45–48].”
Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102821 · Cited by 13
Weerakkody, T. N., Sabelström, H., Andrews, S. V., Chadarevian, J. P., Chin, M. Y., Tatarakis, D., Propson, N. E., Kim, D. J., Theolis, R., Parico, G. C. G., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adw7428 · Cited by 12
Self-citationOtu-Boakye, S., Natarajan, D., Plakkot, B., Raghavendiran, I., Hoppa, P., Kiss, T., Subramanian, M., & Balasubramanian, P. (2026) · GeroScience · doi:10.1007/s11357-025-01986-y · Cited by 9
“LDAMs are characterized by increased reactive oxygen species production and increased secretion of pro-inflammatory cytokines [2, 23].”
InfluentialLipid-associated macrophages and metabolic inflammatory diseases
Zheng, Y., Tu, D., Dong, C., Zhao, H., & Wang, H. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100312 · Cited by 12
“LDAMs in the brains of individuals with neurodegenerative diseases specifically aggregate in pathological regions such as A β plaque-enriched areas and demyelinated lesions (Marschallinger et al., 2020).”
InfluentialMaria Jose Perez, J., Lam, A., Weissleder, C., Bertoli, F., Raji, H., Bosch, M., Nemazanyy, I., Kalb, S., Kehili, M., Hirschberg, I., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02320-1 · Cited by 15
“We show that UPR mt activation triggers a transition toward a dysfunctional state reminiscent of LD-accumulating microglia and senescent microglia, observed near tau and amyloid pathology in the aging brain 69,70 .”
Li, M., Wang, M., Zhao, Y., Zhong, R., Chen, W., Lei, X., Wu, X. O., Han, J., Lei, L., Wang, Q., et al. (2024) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02939-y · Cited by 9
Neuroimmunology and ageing – the state of the art
Bauer, M. E., Pawelec, G., & Paganelli, R. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00411-w · Cited by 11
“…of the NLRP3 inflammasome, increased expression of transcription factors for genes encoding inflammatory proteins (e.g., nuclear transcription factor κ-B, NF-κB), increased secretion of pro-inflammatory cytokines and chemokines, and increased production of reactive oxygen species (ROS) [9].”
BackgroundPalmitoleic acid protects microglia from palmitate-induced neurotoxicity in vitro
Yu, Q., Yang, Y., Xu, T., Cai, Y., Yang, Z., & Yuan, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297031 · Cited by 9
Larson, K. C., Martens, L. H., Marconi, M., Dejesus, C., Bruhn, S., Miller, T. A., Tate, B. A., & Levenson, J. M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03029-3 · Cited by 9
Fernández‐Blanco, Á., Sierra, C., Tejido, C., & Dierssen, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063289 · Cited by 6
“Some of these states are referred to as Disease-Associated Microglia (DAM), and they are linked to various neurological disorders [12–17].”
BackgroundYang, P., Liu, Y., Tong, Z., Huang, Q., Xie, X., Mao, S.-Y., Ding, J., Lu, M., Tan, R. X., & Hu, G. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01259-y · Cited by 9
Wu, L., Zhao, Y., Gong, X., Liang, Z., Yu, J., Wang, J., Zhang, Y., Wang, X., Shu, X., & Bao, J. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400660 · Cited by 12
A Novel Localization of METTL7A in Bergmann Glial Cells in Human Cerebellum
Vera-Montecinos, A., Galiano-Landeira, J., Roldán, M., Vidal-Domènech, F., Claro, E., & Ramos, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098405 · Cited by 8
“Lipid-droplet-containing microglia have been described during aging and have been linked to inflammation and cognitive decline [49], both processes which are also related to schizophrenia [18–21,50].”
BackgroundTrem2 Enhances Demyelination in the Csf1r+/− Mouse Model of Leukoencephalopathy
Biundo, F., Chiţu, V., Gökhan, Ş., Chen, E., Oppong‐Asare, J., & Stanley, E. R. (2023) · Biomedicines · doi:10.3390/biomedicines11082094 · Cited by 9
Saito, K., Goulding, D. S., Nolt, G. L., Dimas, S. H., Moore, L. C., Stevens, I. O., Anderson, S., Snipes, J. A., Macauley, S. L., Nelson, P. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.16.654329 · Cited by 9
Li, Y., Fu, J., & Tzeng, S. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105792 · Cited by 8
Zhang, B., Chen, J., Wang, J., & Pan, X. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.125779 · Cited by 9
Tools to Dissect Lipid Droplet Regulation, Players, and Mechanisms
Liu, J., & Aye, Y. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.4c00835 · Cited by 8
Is age-related myelinodegenerative change an initial risk factor of neurodegenerative diseases?
Wu, S., & Chen, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00848 · Cited by 9
“A similar study has observed that the microglia in the aged brain accumulate lipid droplets, which impair their phagocytic ability and increase the production of reactive oxygen species and pro-inflammatory cytokines (Marschallinger et al., 2020).”
PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases
Shi, Y., Hou, W., Li, B., & Zhu, C. (2025) · Communications Biology · doi:10.1038/s42003-025-08272-9 · Cited by 9
Lipids: Driving Forces in the Underlying Biology of Carcinogenesis
Chakraborty, S., Kumar, A. S., & Banerjee, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00170 · Cited by 9
Zhang, H., Huang, Y. P., & Wang, W. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111556 · Cited by 9
Interplay Between Aging and Glial Cell Dysfunction: Implications for CNS Health
García‐Domínguez, M. (2025) · Life · doi:10.3390/life15101498 · Cited by 12
Gong, K., Zhang, S., Pan, Y., Cai, Q., Wu, M., Yin, X., Ma, J., Ji, H., Wang, Z., Wu, W., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02196-6 · Cited by 8
“It has been reported that carnitine plays a vital role in long-chain FAO [38] and the accumulation of lipid droplets in microglia has been proved as a key trigger for neuroinflammation [40].”
Sterile innate immune mechanisms in neurodegenerative diseases
Ealy, A., Serapiglia, A. M., & Panicker, N. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111039 · Cited by 8
“An unbiased CRISPR–Cas9 screen to identify drivers of LD generation within microglia identified multiple genes associated with neurodegenerative disease, including GRN (mutations which are associated with FTD) and VPS35 (mutations associated with PD) (146).”
Zhang, F., Lv, T., Xu, T., Li, J., Lian, J., Lin, S., Hu, Q., Jin, Y., Feng, J., & Zhang, X. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103978 · Cited by 8
Microglia Mitochondrial Metabolism in Neurological Diseases
Wang, J., Gao, Y., Chen, Q., Xiong, X., Miao, S., Chen, X., Tang, Y., & Gu, L. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05640-8 · Cited by 10
“Contra the traditional view of lipid accumulation as a passive storage phenomenon, we interpret the LLM state as a terminal “metabolic paraly-sis” distinct from classical activation [37, 208].”
Yadav, A., Ouyang, X., Barkley, M., Watson, J. C., Madhamanchi, K., Kramer, J., Zhang, J., & Melkani, G. C. (2026) · Aging Cell · doi:10.1111/acel.70439 · Cited by 9
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 12
Zhu, X.-L., Zhang, H., Peng, W., Gao, S., Yang, Z., Zhang, J., & Liu, X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.067 · Cited by 7
TMEM106B reduction does not rescue GRN deficiency in iPSC-derived human microglia and mouse models
Domínguez, S. L., Laufer, B. I., Ghosh, A. S., Li, Q., Ruggeri, G., Emani, M., Phu, L., Friedman, B. A., Sandoval, W. N., Rose, C. M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108362 · Cited by 7
Calcium Signalling in Microglia
Garaschuk, O., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_7 · Cited by 7
Sheng, J., Zhang, X., Liang, W., Lyu, J., Zhang, B., Min, J., Xu, A., Xu, X., Li, J. W., Li, J., et al. (2025) · BMC Biology · doi:10.1186/s12915-025-02175-1 · Cited by 6
Wang, H.-C., Liu, K.-Y., Wang, L.-T., Hsu, S.-H., Wang, S.-C., & Huang, S.-K. (2021) · Human Cell · doi:10.1007/s13577-021-00491-6 · Cited by 6
Profiling Microglia in a Mouse Model of Machado–Joseph Disease
Campos, A. B., Duarte‐Silva, S., Fernandes, B., das Neves, S. P., Marques, F., Teixeira‐Castro, A., Neves‐Carvalho, A., Monteiro‐Fernandes, D., Portugal, C. C., Socodato, R., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020237 · Cited by 7
Towards elucidating disease-relevant states of neurons and glia by CRISPR-based functional genomics
Leng, K., & Kampmann, M. (2022) · Genome Medicine · doi:10.1186/s13073-022-01134-7 · Cited by 7
“Furthermore, the accumulation of toxic protein aggregates or other pathological products in a cell could be associated with disease-associated cell states [68, 69].”
BackgroundLi, Q., Kang, X., Liu, L., Xiao, Y. M., Xu, D., Zhuang, H., Liu, H., Zhao, J., Zou, H., Yang, J., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106181 · Cited by 7
Qiu, H., Zhao, R., Fei, G., Pan, X., Sang, S., Xu, Y., Jin, B., Jin, L., Cheng, X., & Zhong, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210213 · Cited by 7
Ceasrine, A. M., Batorsky, R., Shook, L. L., Kışlal, S., Bordt, E. A., Devlin, B. A., Perlis, R. H., Slonim, D. K., Bilbo, S. D., & Edlow, A. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.03.471177 · Cited by 9
Early life high fructose exposure disrupts microglia function and impedes neurodevelopmentPreprint
Wang, Z., Lipshutz, A. B., Liu, Z.-L., Trzeciak, A. J., Miranda, I. C., de la Torre, C. M., Schild, T., Lazarov, T., Rojas, W. S., Saavedra, P. H. V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.14.553242 · Cited by 7
Monroe, K. M., Weerakkody, T. N., Sabelström, H., Tatarakis, D., Suh, J. H., Chin, M. Y., Andrews, S. V., Propson, N. E., Balasundar, S., Davis, S. S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3954863/v1 · Cited by 7
Cuní-López, C., Root, J. T., Hao, Y., Kowal, I., Blomberg, N., Ghirlando, R., Yang, L. G., Koppes-den Hertog, S. J., Cookson, M. R., van der Kant, R., et al. (2025) · doi:10.1101/2025.08.19.669163 · Cited by 8
Reducing brain Aβ burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice
Tsay, H.-J., Gan, Y., Su, Y., Sun, Y., Yao, H.-H., Chen, H., Hsu, Y.-T., Hsu, J. T., Wang, H., & Shie, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116404 · Cited by 6
Martin, M., Debenay, E., Bardinet, J., Peltier, A., Pourtau, L., Gaudout, D., Layé, S., Pallet, V., Dinel, A., & Joffre, C. (2024) · Inflammation Research · doi:10.1007/s00011-024-01947-9 · Cited by 6
Lipidomics Analysis of Human HMC3 Microglial Cells in an In Vitro Model of Metabolic Syndrome
Chmielarz, M., Bromke, M. A., Olbromski, M., Środa-Pomianek, K., Frej−Mądrzak, M., Dzięgiel, P., & Sobieszczańska, B. (2024) · Biomolecules · doi:10.3390/biom14101238 · Cited by 6
Bai, G., Ke, S., Lu, J., Yu, S., Li, S., Fang, M., & Ling, J. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100776 · Cited by 7
Unraveling the complexity of microglial responses in traumatic brain and spinal cord injury
Henry, R. J., & Loane, D. J. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00015-6 · Cited by 7
Mapping the therapeutic landscape of CRISPR-Cas9 for combating age-related diseases
He, Q., Wang, Y., Tan, Z., Zhang, X., Yu, C., & Jiang, X. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1558432 · Cited by 6
New players on lipid droplets: Their regulations and functions
Pan, H., Su, H., & Huang, X. (2025) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2025.102541 · Cited by 7
Xiong, X.-Y., Yuan, H., Mu, Y., He, Y., Xie, F., Feng, X., Xie, J., Pan, X., Wang, Y.-F., Gong, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625673 · Cited by 8
Transcriptional regulation of disease-relevant microglial activation programs
McQuade, A., Mishra, R., Hagan, V., Liang, W., Colias, P. J., Castillo, V. C., Gonzalez, B., Lubin, J. P., Haage, V. C., Marshe, V. S., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.07.001 · Cited by 7
Zheng, Y., Xu, W., Suo, Z., Qu, Y., Lin, L., Zhang, E., Han, D., Wu, M., Hongyi, L. I., Zheng, H., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03566-5 · Cited by 8
“…with distinct functions have been identified, including DAM [12] and terminally inflammatory microglia (TIM) [52] in AD, IFN-I-responsive microglia (IRMs) [16] in the partial whisker deprivation model, and lipid-droplet-accumulating microglia (LDAM) [53] in systemic inflammation models.”
Portugal, C. C., Almeida, T. O., Tedim-Moreira, J., Silva, C., Canedo, T., Galvão, J., Magalhães, A., Summavielle, T., Bai, X., Kirchhoff, F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03588-z · Cited by 7
“Aging microglia show deficits in vesicular trafficking and phagocytic activity, often linked to the accumulation of CD68 + lysosomal vesicles [27].”
Wang, Y., Chen, C.-Y., Yang, X., Lei, L., & Zhang, Y. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111566 · Cited by 9
Yu, R., Lozinski, B. M., Seifert, A., Ta, K., Zandee, S., Kaushik, D. K., Park, J., Klément, W., Larouche, S., Tsimikas, S., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02113-y · Cited by 10
Yang, J., Wang, D., Dong, X., Huo, H., Tao, R., Zhang, Y., Wang, Z., Wang, L., & Zhi, N. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01646-x · Cited by 6
“Transcriptome analysis of neonatal microglia showed that the expression of LD-related genes (such as Plin2 ) was downregulated, the intracellular LD volume was reduced, phagocytosis capacity was increased, and an anti-inflammatory phenotype was displayed (Marschallinger et al. 2020).”
Nayak, A., Bera, S., Purohit, S., & Jain, C. K. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.116019 · Cited by 11
Jia, J., Gan, Y., Li, J., Li, L., Meng, H., Mh, S., Ye, L., Mao, R., Cao, X., Xia, S., et al. (2026) · Advanced Science · doi:10.1002/advs.202517825 · Cited by 7
Tabor, G. T., Litvinchuk, A., Chen, Y., Allison, A., Sun, E. W., van Lengerich, B., Davis, S. S., West, E., Schlachetzki, J. C. M., Zeng, C., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116841 · Cited by 14
“10 Many of these studies have relied on ex vivo or in vitro models to study LD dynamics, but the extent to which the myeloid cell lipid accumulations observed in postmortem human AD brains and mouse models correspond to bona fide LDs has not been definitively determined.”
InfluentialWang, S., Wang, J., Hu, Z., Wu, L., & Huang, L. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115663 · Cited by 7
Reduced triacylglycerols and lipid droplets are associated with resilience to Alzheimer's disease
van der Vliet, D., de Vries, L. E., Di, X., Wever, D. D., de Jong, B., van der Meij, M. T. C., van der Peet, M., Harms, A. C., Hankemeier, T., Swaab, D. F., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71083 · Cited by 6
Haskell, A. K., Kulas, J. A., Carter, W., Javens‐Wolfe, J., Hinkel, R. D., Moussaif, M., Smiley, J. S., Lazaro, O., Robertson, S., Palkowitz, A. D., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71117 · Cited by 6
“42,66,67 Moreover, the late-onset AD risk gene PICALM was recently found to promote the formation of microglial lipid droplets while impairing phagocytosis.”
Microglia in autism spectrum disorder: heterogeneity, immunometabolism, and synapse-related pathways
Lian, A., He, M., Zhang, H., & Yang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783755 · Cited by 7
Shao, Y., Liu, J., Zhao, J., Xue, K., Wu, X., Cao, H., Bao, R., Sun, Q., Zhang, Y., Gao, P., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03859-3 · Cited by 7
Natarajaseenivasan, K., Garcia, A., Velusamy, P., Shanmughapriya, S., & Langford, D. (2022) · iScience · doi:10.1016/j.isci.2022.105407 · Cited by 7
Navarro, E., Efthymiou, A. G., Mattei, D., Parks, M., Riboldi, G. M., Vialle, R. A., Udine, E., Muller, B. Z., Humphrey, J., Allan, A., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03967-0 · Cited by 6
The impact of mild episodic ketosis on microglia and hippocampal long‐term depression in 5xFAD mice
Lucente, J. D., Ramsey, J. J., Jin, L., & Maezawa, I. (2024) · FASEB BioAdvances · doi:10.1096/fba.2024-00123 · Cited by 8
“…known direct actions include its activation of cell surface receptors HCAR2 (hydroxycarboxylic acid receptor 2) and FFAR3 (free fatty acid receptor 3), inhibition of histone deacetylases (HDACs) to affect epigenetics, modulation of potassium channel function, and direct β - hydroxybutyrylation of…”
Zhang, L., Peng, C., Chu, Y.-Q., Zhou, Z.-M., Hua, R., & Zhang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1412699 · Cited by 8
APOEε4 alters ApoE and Fabp7 in frontal cortex white matter in prodromal Alzheimer's disease
Moreno‐Rodríguez, M., Perez, S. E., Malek‐Ahmadi, M. H., & Mufson, E. J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03349-y · Cited by 8
Theodosis‐Nobelos, P., & Rekka, E. A. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130194 · Cited by 6
Glucose uptake in pigment glia suppresses Tau-induced inflammation and photoreceptor degeneration
Oka, M., Nakajima, S., Suzuki, E., Yamamoto, S., & Ando, K. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052057 · Cited by 7
Cheng, Y., Li, J., Yu, H., Li, S., Tychhon, B., Cheng, C., & Weng, Y. (2025) · Toxicology · doi:10.1016/j.tox.2025.154198 · Cited by 8
Kaczmarek, P., & Rupik, W. (2020) · Journal of Morphology · doi:10.1002/jmor.21311 · Cited by 6
Portero‐Otín, M., Torres, P., & Pamplona, R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.363832 · Cited by 6
The progranulin cleavage product granulin 3 exerts a dominant negative effect on animal fitness
Wang, A. L., Mambou, E. A., & Kao, A. W. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad184 · Cited by 6
Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age
Kellogg, C. M., Pham, K. D., Ko, S.-H., Cox, J. E. J., Machalinski, A. H., Stout, M. B., Sharpe, A. L., Beckstead, M. J., Chucair‐Elliott, A. J., Ocañas, S. R., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108413 · Cited by 10
Yi, W., Lv, D., Sun, Y., Mu, J., & Lu, X. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149414 · Cited by 8
An inside job: New roles for ApoE at the lipid droplet
Feringa, F. M., & van der Kant, R. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202402171 · Cited by 6
Microbial and immune factors regulate brain maintenance and aging
Travier, L., Singh, R., Fernández, D. S., & Deczkowska, A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102607 · Cited by 6
Metadata
- Authors
- Marschallinger, J., Iram, T., Zardeneta, M., Lee, S. E., Lehallier, B., Haney, M. S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D. W., Kim, J., Tevini, J., Felder, T. K., Wolinski, H., Bertozzi, C. R., Bassik, M. C., Aigner, L., & Wyss-Coray, T.
- Affiliations
- Paracelsus Medical University (AT)
- Stanford Medicine (US)
- Stanford University (US)
- Howard Hughes Medical Institute (US)
- University of Graz (AT)
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2020-01-20
- Volume
- 23
- Issue
- 2
- Pages
- 194-208
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC7595134
- OpenAlex
- W3000061011
- Cited by
- 1,384
- References
- 101
- Citations by year
- 2026: 266 · 2025: 299 · 2024: 263 · 2023: 190 · 2022: 158 · 2021: 141 · 2020: 66
- FWCI
- 45.97
- Type
- journal article
- Language
- en
- Update notices
- Open access
- green
- doi.org
- Locations
- Nature Neuroscience (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- Austrian Science Fund (T736)
- National Institutes of Health (1dp2hd084069-01)
- National Institute on Aging (AG053015, DP1 AG053015)
- National Human Genome Research Institute (T32HG000044)
- National Institute of General Medical Sciences (R37 GM058867, R01GM058867)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (DP2 HD084069)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- microglia, lipid droplets, brain aging, neuroinflammation, phagocytosis, reactive oxygen species, inflammatory cytokines, innate immunity, progranulin, gene regulatory networks, neurodegeneration, hippocampus, CRISPR-Cas9 screen, lipid droplet formation
- MeSH terms
- Aging, Animals, Brain, Humans, Inflammation, Lipids, Microglia, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-13, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-13 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review